fashion -WSS

fashion

author：explore 2025-09-28 15:55:13 - browse：335

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： H.R. 3 is the wrong path to lower drug costs

WSS

CDC recommends RSV monoclonal antibody for infants

FDA scientists endorse Pfizer/BioNTech Covid

The cancer stories no one wants to hear

Medicare proceeds with plan to claw back hospital funds

Medicare slashes safety net hospital payments by nearly $1 billion

Biotech startup Celsius cuts 75% of staff ahead of first trial start

entertainment

fashion

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Coloradans with cystic fibrosis could lose access to Trikafta

23andMe had bad news about my health. I wish a person had delivered it

It costs an awful lot of money to give away a kidney

Cancer drug shortages should be causing more outrage

After Sarepta trial failure, Duchenne families brace for more debate

Peter Hotez and the public health issue of online harassment

Lung cancer screening guidelines updated for cigarette smokers

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How to ethically and practically extend health care to all

Wikipedia

The cancer stories no one wants to hear

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

2 officers injured in shooting in Orlando, police say

Flint parents haunted by uncertainty, fears of lead poisoning

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Florida officials tell state schools to teach AP Psychology 'in its entirety'

hotspot

focus

leisure time

hotspot